New analysis of a drug approved for osteoporosis prevention and treatment has provided definitive evidence that the medication is also effective as a breast cancer preventative for certain cancers. Women who took the drug raloxifene were less likely to develop invasive, estrogen-receptor (ER) positive breast cancer compared with women who did not take the drug.

More: continued here

This entry was posted on Wednesday, June 11th, 2008 at 5:06 pm and is filed under Breast Cancer. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.